Fighting antibiotic resistance
Antimicrobial resistance (AMR) is recognized by the World Health Organization (WHO) as one of the top ten global health threats, with severe implications for public health. Alarmingly, every 45 seconds, someone dies from an antibiotic resistant infection.
AMRx® platform powered by Azure OpenAI is an advanced, culture-free, AI/ML based urinary tract infection (UTI) diagnostic tool.
Analysing patterns
AMRx utilises AL/ML and leverages patient clinical history to accurately predict UTIs, identify causative organisms, and determine antibiotic resistance or susceptibility patterns without the need for traditional cultures.
Microsoft products used for the development of AMRx® are Azure Machine Learning, Azure SQL, Azure OpenAI, Azure Front door and Azure WebApp.
By reducing unwarranted clinical investigations, AMRx saves valuable time, effort, and resources. This efficiency is particularly beneficial in resource limited settings.
AMRx® delivers precise diagnosis in 5 minutes thereby reducing cost. It also seeks to address the 10 million annual deaths by enabling rapid clinical decisions.
Innominds is an AI-first, platform-led digital transformation and full cycle product engineering services.
More details at https://www.microsoft.com/en-in/aifirstmovers/innominds-software
